Today: 21 July 2026
Browse Category

NASDAQ:CETX 6 December 2025 - 9 January 2026

Cemtrex (CETX) stock jumps 33% in premarket after Invocon deal closes — what to watch nextNew York,

Cemtrex (CETX) stock jumps 33% in premarket after Invocon deal closes — what to watch nextNew York,

Cemtrex Inc shares rose about 33% in U.S. premarket trading on Friday after the company said it had completed its acquisition of aerospace and defense engineering firm Invocon. The stock was at $3.86 at around 5:40 a.m. EST, after closing Thursday up 9.9% at $2.90. A filing showed Cemtrex paid $7.06 million in cash and said Invocon financial statements and pro forma information will be filed later in an amended report.
Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

December 23, 2025 — Cemtrex, Inc. is ending the year the way micro-caps often do: loudly. After a sharp, high-volume jump in the latest session, traders are now weighing a cluster of late-2025 catalysts—most notably a near-term aerospace-and-defense acquisition, a new industrial-services LOI, and multiple financing and capital-structure updates that can materially change the share count. SEC+4StockAnalysis+4Cemtrex, Inc.+4
23 December 2025
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

On Monday, December 8, Cemtrex shares closed at $7.05, up 129.64% from Friday’s close of $3.07, after trading in an extraordinary intraday range of $4.84 to $9.70. StockAnalysis+2StockInvest+2Pre‑market quotes early Tuesday show the stock giving back part of that move, trading around the low‑$6 area, but still far above last week’s levels. StockAnalysis+1
Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks traded mostly flat on Monday as Wall Street headed into a crucial Federal Reserve meeting, but under the surface the tape was anything but quiet. While the S&P 500 and Dow Jones Industrial Average hovered around unchanged and the Nasdaq 100 eked out a small gain, small‑cap and high‑beta names ripped higher, led by a wave of biotech catalysts and a blockbuster AI‑data takeover.
Cemtrex (CETX) Stock Update for December 6, 2025: Price Action, Reverse Split, Aerospace Pivot and 2026 Outlook

Cemtrex (CETX) Stock Update for December 6, 2025: Price Action, Reverse Split, Aerospace Pivot and 2026 Outlook

As of December 6, 2025, Cemtrex, Inc. sits at the intersection of aggressive strategic expansion and extreme share-price volatility. After a series of reverse stock splits, equity raises, and new acquisition plans, the micro‑cap security and industrial services company is attempting to reinvent itself with a new aerospace and defense segment—while technical and algorithmic models remain broadly bearish on the stock. Cemtrex, Inc.+2Cemtrex, Inc.+2
6 December 2025
Go toTop